After landmark deal, AstraZeneca goes to CSPC again in up to $1.7B pact

July 2, 2026 01:06 PM EDT DealsChinaPharma Af­ter land­mark deal, As­traZeneca goes to CSPC again in up to $1.7B pact Kyle LaHucik Biotech Correspondent Less than six months af­ter lin­ing up one of the largest biobucks pack­ages in in­dus­try his­to­ry, As­traZeneca is re­turn­ing to the same Chi­nese part­ner for … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER